search
Back to results

Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD) (TH-CBT)

Primary Purpose

Depression, Parkinson's Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TH-CBT
Standard Care
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring Depression, Telehealth, Parkinson's Disease, Veterans, Care-partners, Cognitive-Behavioral Therapy, Caregiver

Eligibility Criteria

35 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Confirmed PD diagnosis in the VA medical record
  • Primary Major Depression, Dysthymia, or Depression Not Otherwise Specified (NOS) of at least moderate severity per the Structured Clinical Interview (SCID) for Diagnostic and Statistical Manual of Mental Disorders (DSM5) Disorders.
  • Access to a computer/tablet with high-speed internet access. primary
  • Ages 35-85
  • Stable medication and mental health regimen greater than or equal to 6 weeks, including:

    • applicable antidepressants
    • other psychotropic agents
    • movement disorder drugs
    • clinic-based psychotherapies
  • Willingness to involve a family member or friend to participate

Exclusion Criteria:

  • Possible dementia or marked cognitive impairment [Montreal Cognitive
  • Assessment Score (MoCA) less than 21
  • Motor fluctuations greater than or equal to 50% of the day
  • Suicidal plans or intent (determined by clinical interview)
  • Unstable medical conditions

Sites / Locations

  • Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Other

Arm Label

TH-CBT + Standard Care

Standard Care

Arm Description

Cognitive-behavioral therapy delivered via telehealth with a focus on decreasing depressive symptoms in Parkinson's Disease (PD).

VA standard care depression in Parkinson's Disease (PD)

Outcomes

Primary Outcome Measures

Hamilton Depression Rating Scale
This measure uses the Hamilton Depression Rating Scale (HDRS) to express the average severity of depressive symptoms, with higher scores indicating greater depression. Hamilton Depression Rating Scale (HAMD) Score Min:0 and Max: 52. Higher scores mean a worse outcome.

Secondary Outcome Measures

Full Information

First Posted
June 17, 2015
Last Updated
July 19, 2023
Sponsor
VA Office of Research and Development
Collaborators
Department of Veterans Affairs, New Jersey, Rutgers Robert Wood Johnson Medical School
search

1. Study Identification

Unique Protocol Identification Number
NCT02475954
Brief Title
Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)
Acronym
TH-CBT
Official Title
Telehealth Cognitive-Behavioral Therapy for Depression in Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
July 15, 2016 (Actual)
Primary Completion Date
December 10, 2019 (Actual)
Study Completion Date
December 10, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
Collaborators
Department of Veterans Affairs, New Jersey, Rutgers Robert Wood Johnson Medical School

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
When Veterans with Parkinson's disease (PD) suffer from depression, they are more likely to experience disease complications, interpersonal difficulties with caregivers, and poorer quality of life. Unfortunately, depression in Veterans with PD is inadequately treated at the current time. Treatment for depressed Veterans with PD will require the elimination of geographical barriers to care and approaches that address the unique aspects of PD. The proposed study will be the first to explore a novel and innovative, PD-informed psychotherapy package for depressed Veterans with PD and their Caregivers, delivered through video-to-home telehealth. If the results of this proposal are promising, a much needed treatment can be made available to Veterans with PD and their Caregivers across the country, regardless of geographical location.
Detailed Description
Objective: There is a critical need for treatments that address depression and barriers to mental health care among the nearly 100,000 Veterans with Parkinson's Disease (PD) served by the VA. Depression in PD (dPD) is a major complicating factor in the movement disorder, affecting several key functional outcomes such as motor disability, cognitive status, quality of life, and caregiving relationships. The challenge to meeting the treatment needs of Veterans with dPD centers on the lack of clinicians who are knowledgeable about the interactions of PD and depression, the considerable transportation barriers faced by this population, combined with the geographical dispersion of specialized services within the VA, and the paucity of effectiveness research that informs treatments for dPD. The proposed study seeks to overcome these challenges by using a telehealth delivery platform (i.e., video-to-home) to test the effectiveness of a 10-session cognitive-behavioral treatment (CBT) package that has been tailored to address the unique needs of depressed Veterans with PD. The proposed treatment package also provides support and skills-training to the Veteran's Caregiver (3 sessions). This HSR&D proposal will be the first to: 1) to evaluate the effectiveness of TH-CBT for improving Veteran outcomes in dPD, 2) to examine the impact of TH-CBT for dPD on a variety of Caregiver outcomes, and 3) to assess Veteran and Caregiver perspectives on TH-CBT using a mixed-methods sequential explanatory design. Method: A PD-informed, telehealth-administered cognitive behavioral therapy package (TH-CBT) for dPD will be evaluated in a clinical effectiveness trial. 180 participants (90 Veterans and 90 Caregivers) will be enrolled. Half of the sample will receive the study treatment package (TH-CBT), in addition to their standard medical care. The other half will only receive standard medical care. The two groups will be compared at baseline, midpoint (week 5), endpoint (week 10), and 1 and 6 months post treatment. Veterans will be assessed with standard measures of depression, anxiety, quality of life, and motor function, while Caregivers will be evaluated with measures of caregiver burden, empowerment, and communication. Impact: Given the public health impact of improved depression treatment in Veterans with Parkinson's disease, the knowledge to be gained may be significant and the project could directly impact clinical practice. The data gleaned from this study will guide the wide-scale implementation of this remote care model within the VA for meeting the specialized needs of Veterans with PD. Towards this goal, successful results for the proposed study will facilitate a multisite initiative to further examine issues of dissemination, implementation, and effectiveness, using a hybrid research design. Ultimately, these Health Science Research & Development (HSR&D) data may support the development of a centralized care model, in which highly specialized dPD providers, concentrated in a few locations, provide specialty care to Veterans and Caregivers across the country.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Parkinson's Disease
Keywords
Depression, Telehealth, Parkinson's Disease, Veterans, Care-partners, Cognitive-Behavioral Therapy, Caregiver

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
174 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TH-CBT + Standard Care
Arm Type
Active Comparator
Arm Description
Cognitive-behavioral therapy delivered via telehealth with a focus on decreasing depressive symptoms in Parkinson's Disease (PD).
Arm Title
Standard Care
Arm Type
Other
Arm Description
VA standard care depression in Parkinson's Disease (PD)
Intervention Type
Behavioral
Intervention Name(s)
TH-CBT
Intervention Description
The TH-CBT group will receive the study intervention and standard care. The study treatment has been previously manualized and modified for remote administration, as described in the introduction to the revised application.12 PD Veterans will receive 10 weekly individual sessions (60 minutes each) of CBT, delivered via Video-to-Home (V2H).
Intervention Type
Other
Intervention Name(s)
Standard Care
Intervention Description
Standard Care is defined as medical and psychiatric treatment provided by patients' personal doctors (e.g., neurologists, psychiatrists, therapists). Veterans will continue to receive routine clinical care and will remain on all depression treatments that they were receiving prior to their study (e.g., stable anti-depressant medications, established psychotherapy, clinical monitoring).
Primary Outcome Measure Information:
Title
Hamilton Depression Rating Scale
Description
This measure uses the Hamilton Depression Rating Scale (HDRS) to express the average severity of depressive symptoms, with higher scores indicating greater depression. Hamilton Depression Rating Scale (HAMD) Score Min:0 and Max: 52. Higher scores mean a worse outcome.
Time Frame
10 weeks (endpoint) and 6 months post-treatment
Other Pre-specified Outcome Measures:
Title
Family Empowerment Scale
Description
The Family Empowerment scale measures the degree to which caregivers feel empowered to help care for their Veteran. To obtain a score for each area, sum the item responses where "Not at all" is scoring as 1, "Mostly not true" is scored as 2, "Somewhat true" is scored as 3, "Mostly true" is scored as 4, and "Very true" is scored as 5 to produce a score ranging from 12-60. The items are scored in the same direction, i.e., no item scores are reversed, and a higher score indicates relatively more empowerment in each respective area. Higher scores mean a better outcome.
Time Frame
10 weeks (endpoint) and 6 months post-treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Confirmed PD diagnosis in the VA medical record Primary Major Depression, Dysthymia, or Depression Not Otherwise Specified (NOS) of at least moderate severity per the Structured Clinical Interview (SCID) for Diagnostic and Statistical Manual of Mental Disorders (DSM5) Disorders. Access to a computer/tablet with high-speed internet access. primary Ages 35-85 Stable medication and mental health regimen greater than or equal to 6 weeks, including: applicable antidepressants other psychotropic agents movement disorder drugs clinic-based psychotherapies Willingness to involve a family member or friend to participate Exclusion Criteria: Possible dementia or marked cognitive impairment [Montreal Cognitive Assessment Score (MoCA) less than 21 Motor fluctuations greater than or equal to 50% of the day Suicidal plans or intent (determined by clinical interview) Unstable medical conditions
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alejandro Interian, PhD
Organizational Affiliation
Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ
City
Lyons
State/Province
New Jersey
ZIP/Postal Code
07939
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30955991
Citation
Pontone GM, Dissanayaka N, Dobkin RD, Mari L, Marsh L, Vernaleo BA, Weintraub D, Mari Z. Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease. Am J Geriatr Psychiatry. 2019 Jul;27(7):712-719. doi: 10.1016/j.jagp.2019.03.005. Epub 2019 Mar 13.
Results Reference
result
PubMed Identifier
33710659
Citation
Dobkin RD, Mann SL, Weintraub D, Rodriguez KM, Miller RB, St Hill L, King A, Gara MA, Interian A. Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment. Mov Disord. 2021 Nov;36(11):2549-2558. doi: 10.1002/mds.28548. Epub 2021 Mar 12.
Results Reference
result

Learn more about this trial

Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)

We'll reach out to this number within 24 hrs